FindTrial
Sign In

Evaluation of Cardioprotective Nutrition in people with Metabolic Syndrome and High Blood Pressure: a randomized clinical trial

Evaluation of the effectiveness of Cardioprotective Nutrition in patients with Metabolic Syndrome and High Blood Pressure: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9v9r6vj
Enrollment
Unknown
Registered
2024-04-12
Start date
2023-09-26
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

This is a single-blind, randomized controlled clinical study In which patients will arrive by spontaneous demand, and according to the order in which they accept to participate in the research, they w
and group 2 will also consist of 300 individuals who will follow the low-calorie diet. The total sample will consist of 600 participants, being adult men and women, over 20 years old, hypertensive, wi
F01.829.458.205.500

Sponsors

Universidade do Estado da Bahia - UNEB
Lead Sponsor
Universidade do Estado da Bahia - UNEB
Collaborator

Eligibility

Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults and elderly people. Both sexes. Minimum age of 20 years. Diagnosis of hypertension (140 and/or 90 mmHg). Patients with metabolic syndrome. based on the IDF diagnosis (International Diabetes Federation, 2006)

Exclusion criteria

Exclusion criteria: Pregnant women;nursing mothers; patients with severe heart failure;undergoing gastroplasty;with liver and/or kidney failure;previous history of encephalopathy or anasarca;with any and all neurocognitive conditions or with mental disorders (defined by their clinical history) will not be included in the research. or in clinical investigation); transplanted patients;patients with gastroplasty and those who have a life expectancy equal to or less than 6 months (eg those with malignant metastasis); wheelchair users, patients undergoing treatment for all and any type of cancer and those with difficulties to feed orally

Design outcomes

Primary

MeasureTime frame
The cardioprotective diet is expected to improve blood pressure values.—

Secondary

MeasureTime frame
The cardioprotective diet is expected to improve biochemical parameters (HDL-cholesterol, triglycerides, glycated hemoglobin, fasting glycemia, total cholesterol, low-density lipoprotein (LDL-c) and ultra-sensitive C-reactive protein) and anthropometric parameters (waist circumference, ; body weight, BMI, lean mass and fat mass)—

Countries

Brazil

Contacts

Public ContactEdilene Maria Araújo

Universidade do Estado da Bahia - UNEB

dilaq@msn.com+55(71) 999772922

Outcome results

None listed

Source: REBEC (via WHO ICTRP)